How to Prepare and Store Research Peptides?

📖 Contextual disclaimer
The following article is of an educational nature and is an overview of the principles of laboratory work with peptides as research reagents (Research Use Only). The procedures described are in a research context and do not constitute medical advice or a protocol for human use. Research peptides are not medicinal products, dietary supplements or foodstuffs.
A peptide with HPLC purity ≥98% is no better than a peptide with 90% purity if you work with it incorrectly. You can buy the best reagent in Europe, dissolve it in the wrong buffer, store it at the wrong temperature and within a week receive a sample that looks completely different in mass spectrometry fragmentation than in the production certificate.
Laboratory practice with peptides is not a formality. This is a set of techniques that determine whether the result of your experiment actually concerns the amino acid sequence described in the COA – or its partially degraded descendant. The guide below summarizes everything a research team should know before opening the first vial of lyophilized material: from solvent selection, through reconstruction techniques, to cold storage logistics and interpretation of quality documents.
The article links to more detailed guides. When you see the link “→ full guide” – there you will find an explanation of a specific topic.

Contents

1. Before you open the vial – conditions, tools, hygiene
2. Bacteriostatic water and other working solvents
3. Peptide reconstitution – step by step technique
4. Peptide calculator – how to calculate concentrations and volumes
5. Storage – lyophilisate vs. working solution
6. Cold chain – quality logistics from synthesis to the laboratory
7. HPLC and COA – How to read quality documents
8. The most common mistakes when working with research peptides
9. FAQ
10. Bibliography

1. Before you open the vial – conditions, tools, hygiene

Freeze-dried peptides are relatively stable as a solid, but the moment the vial is opened, a new chapter in their life begins. From now on, they come into contact with air, moisture, and potentially with the surrounding microflora – and as chains of amino acids, they are sensitive to the hydrolysis of peptide bonds, oxidation of cysteine ​​and methionine residues, and deamidation of asparagine and glutamine.

1.1 Temperature of the vial upon opening

A vial straight from the freezer (-20°C) or refrigerator (2-8°C) is colder than the surrounding air. When you open it immediately, the moisture in the air will condense on the inner walls. A drop of water in contact with the lyophilized product begins the hydrolysis of amide bonds – especially for peptides with labile bonds, such as BPC-157 Whether TB-500.
20-minute rule: remove the vial from the refrigerator 15-20 minutes before opening. Let it come to room temperature in a closed container. Only then remove the aluminum cap and puncture the septum.

1.2 Cleanliness of the workplace

The minimum standard for working with RUO peptides is:

• surface disinfected with 70% ethanol or isopropanol
• nitrile gloves (latex may react with some peptides)
• disposable insulin syringes (type U100, 0.3 or 0.5 mL with integral needle 29–31G)
• vial of solvent (bacteriostatic water, water for injection or phosphate buffer pH 7.4 depending on the peptide)
• paper to wipe up any spills

Work in semi-sterile conditions (laminar bed) is not required for most peptides reconstructed for short-term storage in a bacteriostatic solution, but is recommended for peptides intended for long-term storage in dissolved form.

1.3 Materials that never come into contact with the peptide

• Unmarked distilled water from a laboratory tap – may contain traces of metals and microflora
• Organic solvents without indication in the literature (DMSO is sometimes justified only for a few peptides, e.g. some melanocortin fractions)
• Reusable syringes – risk of trace cross-contamination

2. Bacteriostatic water and other working solvents

Bacteriostatic water (BAC water) is sterile water for injection with the addition of benzyl alcohol at a concentration of 0.9%. Benzyl alcohol acts as a mild preservative – it inhibits the growth of most bacteria and fungi, allowing multiple withdrawals from the same vial without rapid microbial contamination.

2.1 Why bacteriostatic and not “for injection”

Water for injection (WFI) is sterile when filled into the vial, but does not contain a preservative. After the first puncture of the septum, microflora from the air begins to colonize the solution – after 24 hours the sample may already be contaminated. For a study that requires multiple time points from a single vial of peptide, this is a logistical problem.
Bacteriostatic water allows for repeated collections within a typical period of 28 days from the first puncture, which corresponds to the average experimental cycle for pharmacokinetic studies in animal models.

2.2 When bacteriostatic is not optimal

For peptides sensitive to a slightly alkaline environment (bacteriostatic has a pH of approximately 5.0–5.5 after the addition of benzyl alcohol) or for cell culture applications, sterile water for injection or PBS phosphate buffer may be a better choice. For GHK-Cu (copper peptide), some test protocols recommend sterile water without preservatives to exclude the interaction of benzyl alcohol with the copper ion.
→ Complete guide to solvent selection: bacteriostatic water – what is it and how to use it · product available in the catalog: bacteriostatic water 10 mL

2.3 Solvent volume – strategic decision

The amount of water you add to the vial determines the final concentration of peptide in the solution. The smaller the volume, the more concentrated the solution – and the less room for error when sampling small volumes.
Typical working concentrations:

Vial size	Water volume	Final concentration
2 mg	1 mL	2 mg/mL (2000 µg/mL)
5 mg	2 mL	2.5 mg/mL
5 mg	1 mL	5 mg/mL
10 mg	2 mL	5 mg/mL
10 mg	1 mL	10 mg/mL

The choice of volume is a compromise between dosing convenience and peptide stability – more dilute solutions (≤1 mg/mL) tend to be less stable for some sequences. A dedicated tool is helpful for concentration planning processes:
→ peptide calculator — calculates the solvent volume and sample volume for a given concentration (see section 4 for details).

3. Peptide reconstitution – step by step technique

Reconstitution is the process of converting the lyophilisate back to the liquid phase. Sounds simple – add water to the powder. In practice, the technique determines whether the peptide will maintain sequence integrity or partially undergo mechanical or hydrolytic degradation in the first minutes after reconstitution.

3.1 Standard procedure (generalized)

1. Bring the peptide vial and solvent vial to room temperature (15-20 minutes outside the refrigerator in a closed container).
2. Disinfect the septa of both vials with 70% isopropanol. Wait 30 seconds for the alcohol to evaporate.
3. Draw up the solvent with a sterile syringe. Typical volume – see table in section 2.3.
4. Insert the needle into the peptide vial at a 45° angle – direct the water stream at the wall of the vial, not directly at the lyophilized product. Direct impact of the jet on a solid can cause micromechanical degradation of the peptide.
5. Do not shake the vial. Roll it gently between your fingers in a circular motion for 15-30 seconds. Shaking generates air bubbles that can denature the peptide at the air/water interface (a phenomenon known from protein chemistry).
6. Wait 5-10 minutes until completely dissolved. The lyophilisate appears to dissolve in a few seconds, but full diffusion through the porous structure takes time.
7. Label the vial with the reconstitution date, final concentration and batch ID. Batch documentation is important for the reproducibility of results across research teams.

3.2 Peptides requiring a different procedure

Some peptides have separate recommendations that result from their chemical specificity:

• GHK-Cu – copper peptide, some protocols recommend preparing a fresh solution just before use, without long-term storage in solution.
• Melanotan II – light sensitive, store the reconstituted vial in the refrigerator in protective packaging (aluminum foil or a light-tight container).
• Oxytocin – in aqueous solution, stability is measured in days, not weeks; the preferred acetate buffer in the pharmacological literature.
• PEG-MGF – Relatively sensitive to repeated freeze-thaw cycles; reconstitute in one serving for use.

→ Full step-by-step guide with photos of the procedure: how to dissolve peptides – step by step guide

3.3 What not to do when reconstituting

• Do not pipette the peptide with the tip touching the walls or bottom of the vial – risk of sample contamination.
• Do not use syringes with a needle shorter than 13 mm (standard insulin needle) in high septum vials – the needle may not reach the liquid level.
• Do not reconstitute the vial twice. Draw multiple times from one reconstitution, but do not add another portion of solvent after partial use.
• Do not mix two different peptides in one vial. Each peptide has its own pharmacokinetics and stability in solution; stack in one vial means a change in parameters that you will not find in the literature.

4. Peptide calculator – how to calculate concentrations and volumes

Converting milligrams to micrograms and micrograms to IU units of an insulin syringe is the source of most errors when working with peptides. The situation is complicated by the fact that insulin syringes have an IU scale (insulin units, where 100 IU = 1 mL), and peptide concentrations are given in µg/mL or mg/mL.

4.1 Basic mathematics

For a 5 mg vial of peptide reconstituted in 2 mL of bacteriostatic water:

• Concentration: 5 mg / 2 mL = 2.5 mg/mL = 2500 µg/mL
• 1 mL = 100 IU on an insulin syringe
• 1 IU = 0.01 mL
• 1 IU of peptide 2.5 mg/mL = 25 µg

Hence, to take e.g. 250 µg of peptide from this vial, you need: 250 / 25 = 10 IU (0.1 mL).

4.2 When the automatic calculator saves errors

Manual counting works as long as you have one vial in one concentration. When you work in parallel with several peptides in a study with different vial sizes and different reconstitution volumes, automation reduces the risk of an order of magnitude error.
→ One-Peptides Peptide Calculator — you enter the mass of the peptide in the vial, the volume of the solvent and the target volume of the sample — the calculator returns the amount of IU on the insulin syringe. The tool also covers the opposite scenario: how much water to add so that 1 IU corresponds to the given peptide mass.

5. Storage – lyophilisate vs. working solution

The stability of the peptide depends on three environmental parameters: temperature, humidity and light. Each form of peptide – lyophilisate enclosed in a vial, lyophilisate after opening, reconstituted solution – has different requirements.

5.1 Peptide in lyophilized form (unopened)

• Temperature: -20°C for long-term storage (months to years); 2–8°C for a period of up to 30 days
• Light: darkness; original packaging provides protection
• Humidity: the vial is hermetically closed; ambient humidity does not affect as long as the septum is intact
• Stability: most peptides remain chemically integral for 18–24 months at -20°C, although for some (e.g. CJC-1295 DAC, pegylated analogues) the literature suggests longer stability

5.2 Peptide after reconstitution

• Temperature: 2-8°C (refrigerator, not freezer – repeated freezing and thawing cycles destabilize the conformation of the peptide in solution and increase the risk of aggregation and precipitation)
• Light: darkness or diffused light; for sensitive peptides (Melanotan II, GHK-Cu) UV protection is critical
• Stability in BAC water: usually 28 days for resistant sequences, 7–14 days for more labile sequences; after this time, the solution should be replaced
• Bubbles and turbidity: The appearance of turbidity or fine precipitates in the solution is a signal of aggregation – the solution is no longer suitable for tests requiring repeatable purity

5.3 Aliquoting – When you have a large vial

For large batches of peptide (e.g. 50 mg GHK-Cu), it is worth dividing the reconstituted solution into smaller portions in Eppendorf tubes (1.5 mL), freezing them at -80°C and thawing individual aliquots as needed. This reduces the number of freeze-thaw cycles to one per serving.
→ More about stability and freezing cycles: Peptide Storage Guide

6. Cold chain – quality logistics from synthesis to the laboratory

The peptide that leaves the synthesis plant passes through several checkpoints before reaching the laboratory station. Each of these points is a potential point where temperature violations could degrade a batch – even if the HPLC certificate at the time of production indicates ≥98% purity.

6.1 Cold chain stages

1. Synthesis and freeze-drying – controlled clean room conditions
2. QC and certification – HPLC, MS, bioburden test; issuance of COA for the party
3. Refrigerated packaging – thermal insulation, ice packs or dry ice
4. Refrigerated transport – premium courier with a declared temperature option
5. Reception at the distributor’s warehouse – immediate transfer to the -20°C refrigerator
6. Preparation of shipment to the end customer – repackaging in refrigerated conditions
7. Final delivery to the laboratory – recommended unpacking within 24 hours of receipt and transfer to destination refrigerator

6.2 What does “cold chain 2–8°C” mean in practice?

The standard of 2–8°C refers to the temperature range in which the peptide is not exposed to rapid structural changes. Short-term exposure (a few hours) to room temperature during transportation will not usually degrade the peptide, provided that melt-freeze cycles do not occur. Longer exposure to temperatures of 30°C+ (summer, air transport without refrigeration) may cause partial hydrolysis of bonds and aggregation.

6.3 Cold chain verification after delivery

After receiving the parcel, it is worth checking:

• whether the ice packs are not fully defrosted (a small amount of ice in the sachet means that the temperature has been maintained)
• whether the vials show any signs of internal condensation (water drops on the internal walls of the lyophilized product suggest a violation of hermeticity)
• whether the COA provided with the lot matches the lot number on the vial

More information about the QA process and cold chain:
→ One Peptides quality tests and certificates — the website describes analytical methods, cold chain standards and the party’s traceability policy.

7. HPLC and COA – how to read quality documents

Certificate of Analysis (COA) is a document that confirms the parameters of a specific batch of peptide. COA is not a declaration – it is a measurement protocol generated by the QC laboratory based on a sample taken directly from the manufactured batch.

7.1 What should be on the COA

The full certificate includes:

• Batch number – an identifier that allows linking a specific vial with production documentation
• Date of production and date of analysis – two different dates; the analysis date shows when the cleanliness measurement was performed
• Amino acid sequence – one-letter and three-letter notation
• Molar mass – calculated theoretical and confirmed by mass spectrometry (MS)
• HPLC purity – percentage from chromatogram, e.g. 99.12%
• HPLC chromatogram – attached image showing the peptide peak and possible impurities
• MS results – confirmation of identity by comparing the measured mass with the expected mass (accurate to approximately 0.1-1 Da)
• Water content test (Karl Fischer) – typically <5% for freeze-dried products
• Acetic acid content test (TFA content) – residues from SPPS synthesis; usually <10%
• Signature of the person responsible for QC – name, date, laboratory stamp

7.2 How to read an HPLC chromatogram

A chromatogram is a graph of the detector signal (UV absorbance, most often 214 nm) as a function of time. The peptide shows up as a peak – the narrower and taller it is, the better the resolution. Impurities are additional peaks, usually lower ones, that appear before or after the main peak.
HPLC purity 98% means that the area of ​​the main peak is 98% of the sum of the areas of all peaks in the chromatogram. The remaining 2% are impurities – these may include:

• shorter peptide sequences (unfinished SPPS syntheses)
• peptides with single sequence errors (deletion sequences)
• hydrolysis products (degradation during production or storage)
• TFA salts (if the peak appears very early)

7.3 HPLC vs MS – complementarity, not competition

HPLC tells you how much peptide there is in the sample. MS says if it’s actually this peptide. The very high purity of HPLC without MS means the risk that the measured purity concerns a sequence other than the declared one. The modern QC standard for research peptides is HPLC ≥98% + MS confirmation in one COA.
→ Full guide to interpreting the quality certificate: how to read a peptide HPLC certificate · COA documentation for the catalog: quality tests and certificates

8. The most common mistakes when working with research peptides

When a research team reports an unusual result – lack of peptide activity, anomaly in pharmacokinetics, unusual aggregation kinetics – it is worth ruling out operational errors first before considering them as a property of the sequence being tested.
Error 1: Reconstructing a frozen vial without bringing it to room temperature. Condensation of moisture triggers the hydrolysis of peptide bonds. Result: lower purity of the solution than declared in the COA.
Mistake 2: shaking instead of gently turning. Air bubbles denature the peptide at the interface. Effect: partial loss of biological activity of the solution.
Mistake 3: storing the solution in the freezer (-20°C) instead of the refrigerator (2-8°C). Freeze-thaw cycles degrade the structure of the working solution. Effect: visible clouding after several cycles.
Mistake 4: Using the same syringe for different peptides. Cross-contamination. The result: bioactivity measurements suffer from hidden error.
Error 5: Missing batch documentation on the working vial. With many batches in the laboratory, it is impossible to associate the result with a specific batch number. Effect: uniqueness of results between experiments.
Mistake 6: Using distilled water from the lab tap as a solvent. Presence of metals and microflora. Effect: contamination of the solution and risk of artifacts in the experiment.
Error 7: reconstitution of light-sensitive peptides without protection. For Melanotan II and some GHK-Cu analogues, UV light induces photodegradation. Effect: change in the chemical composition of the sample.
Mistake 8: Skipping the TFA test at high concentrations. For culture experiments, TFA residues (trifluoroacetic acid from SPPS synthesis) may affect pH and cell viability. Effect: artifacts in cell tests.

FAQ

Related articles in the knowledge base

• Peptide Reconstitution – Step by Step Guide
• Bacteriostatic water – what it is and how to use it
• Peptide Storage – Temperature, Light, Stability
• How to read an HPLC certificate – guide
• Peptide Calculator – How to Calculate Concentration and Volume
• What to pay attention to when buying research peptides
• HPLC vs MS – methods for analyzing peptide purity

For specific research peptides, please see the product sheets in the catalog: research peptides and SARMs. A certificate of analysis is available for each batch for verification on the website quality tests and certificates.

Bibliography

1. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS (2010). Stability of protein pharmaceuticals: an update
2. Lai M. C., Topp E. M. (1999). Solid-state chemical stability of proteins and peptides
3. Meyer BK, Ni A, Hu B, Shi L (2007). Antimicrobial preservative use in parenteral products: past and present
4. Frokjaer S, Otzen DE (2005). Protein drug stability: a formulation challenge
5. Wang W (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals
6. Chi EY, Krishnan S, Randolph TW, Carpenter JF (2003). Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation

ℹ️ Disclaimer
All One-Peptides products are reagents intended exclusively for laboratory and scientific research (Research Use Only). They are not medicines, dietary supplements or products intended for human consumption. The information in this article is for educational purposes only and does not constitute medical, pharmaceutical or dietary advice.

More articles from this cluster: articles on reconstitution and peptide quality.